ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,328Medicare Part D Prescriptions Filled, Including Refills

Rank: 118 out of 6969

$711K Total Retail Price of All Prescriptions

Rank: 279 out of 6969

552 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 552 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

21% of this provider’s 552 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 13,317 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 1,024 790 1 2
SIMVASTATIN 882 788 2 1
METFORMIN HCL 863 722 3 7
AMLODIPINE BESYLATE 768 714 4 4
OMEPRAZOLE 661 559 5 6
HYDROCHLOROTHIAZIDE 512 399 6 8
LEVOTHYROXINE SODIUM 485 417 7 5
HYDROCODONE-ACETAMINOPHEN 379 285 S3 8 3
ALENDRONATE SODIUM 339 318 9 14
ATORVASTATIN CALCIUM 314 234 10 11
FUROSEMIDE 295 262 11 10
GABAPENTIN 294 214 12 17
GLIPIZIDE 276 231 13 21
METOPROLOL TARTRATE 273 205 14 13
DIOVAN 268 223 15 26
LOVASTATIN 253 220 16 15
CARVEDILOL 233 226 17 25
TAMSULOSIN HCL 212 161 18 23
ATENOLOL 193 151 19 9
IBUPROFEN 175 112 20 29
FINASTERIDE 154 122 21 80
ZOLPIDEM TARTRATE 147 122 22 16
ACTOS 142 120 23 61
INSULIN SYRINGE 132 100 24 60
LANTUS 129 112 25 50
DOXAZOSIN MESYLATE 125 115 26 74
PANTOPRAZOLE SODIUM 119 104 27 31
SPIRIVA 119 92 27 66
HUMALOG 117 88 29 167
KLOR-CON 8 113 104 30 104
TRAMADOL HCL 108 89 31 27
METOCLOPRAMIDE HCL 107 66 32 136
LOSARTAN POTASSIUM 99 88 33 12
SERTRALINE HCL 97 69 34 38
LOVAZA 94 54 35 77
CRESTOR 91 84 36 39
PROAIR HFA 90 57 37 33
AZITHROMYCIN 89 79 38 42
JANUVIA 89 66 38 41
WARFARIN SODIUM 88 85 40 20
CIPROFLOXACIN HCL 85 76 41 64
BENAZEPRIL HCL 81 67 42 18
AMLODIPINE BESYLATE-BENAZEPRIL 80 79 43 91
CLOPIDOGREL 79 64 44 48
POTASSIUM CHLORIDE 78 78 45 30
NAPROXEN 75 61 46 62
CITALOPRAM HBR 75 71 46 34
PEN NEEDLE 73 56 48 196
PREDNISONE 73 62 48 70
CLONIDINE HCL 71 66 50 59
LIPITOR 69 49 51 89
DIOVAN HCT 67 67 52 57
TRICOR 66 55 53 143
SYNTHROID 65 59 54 94
AMOXICILLIN 64 50 55 99
ADVAIR DISKUS 63 55 56 45
FENOFIBRATE 63 46 56 63
RANITIDINE HCL 61 50 58 46
ENALAPRIL MALEATE 57 40 59 56
TRIAMCINOLONE ACETONIDE 56 40 60 55
BENICAR 54 43 61 107
PLAVIX 53 41 62 68
ISOSORBIDE MONONITRATE ER 52 47 63 81
NEXIUM 52 29 63 52
LANTUS SOLOSTAR 51 29 65 154
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.